Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development

Arthritis Research and Therapy

Volumn 14, Issue 5, 2012, Pages

  Cook, Andrew D ^a   Pobjoy, Jarrad ^a   Steidl, Stefan ^b   Dürr, Manuela ^b   Braine, Emma L ^a   Turner, Amanda L ^a   Lacey, Derek C ^a   Hamilton, John A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MORPHOSYS AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MATRIX METALLOPROTEINASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MP1 22E9; UNCLASSIFIED DRUG; COLLAGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CARTILAGE DEGENERATION; CONTROLLED STUDY; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; KNEE OSTEOARTHRITIS; KNEE PAIN; MALE; MOUSE; NONHUMAN; PAIN ASSESSMENT; SYNOVITIS; WILD TYPE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DISEASE COURSE; DISEASE MODEL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; OSTEOARTHRITIS, KNEE; PAIN; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; COLLAGENASES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOARTHRITIS, KNEE; PAIN;

EID: 84866505634     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4037     Document Type: Article

References (46)

1. Burgess AW, Metcalf D. The nature and action of granulocyte-macrophage colony stimulating factors. Blood 1980, 56:947-958.
2. Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008, 8:533-544. 10.1038/nri2356, 18551128.
3. Hamilton JA, Stanley ER, Burgess AW, Shadduck RK. Stimulation of macrophage plasminogen activator activity by colony-stimulating factors. J Cell Physiol 1980, 103:435-445. 10.1002/jcp.1041030309, 6967488.
4. Hamilton JA. Rheumatoid arthritis: opposing actions of haemopoietic growth factors and slow-acting anti-rheumatic drugs. Lancet 1993, 342:536-539. 10.1016/0140-6736(93)91653-4, 8102674.
5. Fleetwood AJ, Lawrence T, Hamilton JA, Cook AD. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J Immunol 2007, 178:5245-5252.
6. Naik SH, Metcalf D, van Nieuwenhuijze A, Wicks I, Wu L, O'Keeffe M, Shortman K. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat Immunol 2006, 7:663-671.
7. Cook AD, Braine EL, Campbell IK, Rich MJ, Hamilton JA. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res 2001, 3:293-298. 10.1186/ar318, 64841, 11549370.
8. Yang YH, Hamilton JA. Dependence of interleukin-1-induced arthritis on granulocyte-macrophage colony-stimulating factor. Arthritis Rheum 2001, 44:111-119. 10.1002/1529-0131(200101)44:1<111::AID-ANR15>3.0.CO;2-1, 11212148.
9. Plater-Zyberk C, Joosten LA, Helsen MM, Koenders MI, Baeuerle PA, van den Berg WB. Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor alpha-independent mouse model. Ann Rheum Dis 2009, 68:721-728. 10.1136/ard.2007.085431, 18495731.
10. Cook AD, Turner AL, Braine EL, Pobjoy J, Lenzo JC, Hamilton JA. Regulation of systemic and local myeloid cell subpopulations by bone marrow cell-derived granulocyte-macrophage colony-stimulating factor in experimental inflammatory arthritis. Arthritis Rheum 2011, 63:2340-2351. 10.1002/art.30354, 21809323.
11. Burmester GR, Feist E, Sleeman MA, Wang B, White B, Magrini F. Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-alpha, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study. Ann Rheum Dis 2011, 70:1542-1549. 10.1136/ard.2010.146225, 3147227, 21613310.
12. Burmester GR, Weinblatt ME, Barbarash O, Vatutin M, Szombati I, Stoilov R, Matsievskaya G, Venalis A, Esfandiari E, Grove G, Saurigny D, Sleeman MA, Godwood A, Magrini F. Mavrilimumab (an anti-GM-CSFRα monoclonal antibody) in subjects with rheumatoid arthritis: results of a phase 2 randomized, double-blind, placebo-controlled study [abstract]. Arthritis Rheum 2011, 63:4044.
13. Iannone F, Lapadula G. The pathophysiology of osteoarthritis. Aging Clin Exp Res 2003, 15:364-372.
14. Spector TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, Pepys MB. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 1997, 40:723-727. 10.1002/art.1780400419, 9125256.
15. Sowers M, Jannausch M, Stein E, Jamadar D, Hochberg M, Lachance L. C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthritis Cartilage 2002, 10:595-601. 10.1053/joca.2002.0800, 12479380.
16. Haywood L, McWilliams DF, Pearson CI, Gill SE, Ganesan A, Wilson D, Walsh DA. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 2003, 48:2173-2177. 10.1002/art.11094, 12905470.
17. Farahat MN, Yanni G, Poston R, Panayi GS. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1993, 52:870-875. 10.1136/ard.52.12.870, 1005218, 8311538.
18. Bondeson J, Blom AB, Wainwright S, Hughes C, Caterson B, van den Berg WB. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum 2010, 62:647-657.
19. Haraoui B, Pelletier JP, Cloutier JM, Faure MP, Martel-Pelletier J. Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. In vivo effects of antirheumatic drugs. Arthritis Rheum 1991, 34:153-163. 10.1002/art.1780340205, 1994912.
20. van der Kraan PM, Vitters EL, van de Putte LB, van den Berg WB. Development of osteoarthritic lesions in mice by "metabolic" and "mechanical" alterations in the knee joints. Am J Pathol 1989, 135:1001-1014. 1880494, 2556924.
21. Blom AB, van Lent PL, Holthuysen AE, van der Kraan PM, Roth J, van Rooijen N, van den Berg WB. Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 2004, 12:627-635. 10.1016/j.joca.2004.03.003, 15262242.
22. Blom AB, Brockbank SM, van Lent PL, van Beuningen HM, Geurts J, Takahashi N, van der Kraan PM, van de Loo FA, Schreurs BW, Clements K, Newham P, van den Berg WB. Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1. Arthritis Rheum 2009, 60:501-512. 10.1002/art.24247, 19180479.
23. Sofat N, Ejindu V, Kiely P. What makes osteoarthritis painful? The evidence for local and central pain processing. Rheumatology (Oxford) 2011, 50:2157-2165.
24. Cook AD, Pobjoy J, Sarros S, Steidl S, Durr M, Lacey DC, Hamilton JA. Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain. Ann Rheum Dis 2012,
25. Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, Gall JA, Maher DW, Cebon J, Sinickas V, Dunn AR. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 1994, 91:5592-5596. 10.1073/pnas.91.12.5592, 44042, 8202532.
26. Campbell IK, Rich MJ, Bischof RJ, Dunn AR, Grail D, Hamilton JA. Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J Immunol 1998, 161:3639-3644.
27. van der Kraan PM, Vitters EL, van Beuningen HM, van de Putte LB, van den Berg WB. Degenerative knee joint lesions in mice after a single intra-articular collagenase injection. A new model of osteoarthritis. J Exp Pathol (Oxford) 1990, 71:19-31. 1998679, 2155638.
28. Inglis JJ, McNamee KE, Chia SL, Essex D, Feldmann M, Williams RO, Hunt SP, Vincent T. Regulation of pain sensitivity in experimental osteoarthritis by the endogenous peripheral opioid system. Arthritis Rheum 2008, 58:3110-3119. 10.1002/art.23870, 18821665.
29. Bove SE, Flatters SJ, Inglis JJ, Mantyh PW. New advances in musculoskeletal pain. Brain Res Rev 2009, 60:187-201. 10.1016/j.brainresrev.2008.12.012, 19166876.
30. Plater-Zyberk C, Joosten LA, Helsen MM, Hepp J, Baeuerle PA, van den Berg WB. GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice. Ann Rheum Dis 2007, 66:452-457. 1856054, 17020908.
31. van Lent PL, Blom AB, Schelbergen RF, Sloetjes A, Lafeber FP, Lems WF, Cats H, Vogl T, Roth J, van den Berg WB. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. Arthritis Rheum 2012, 64:1466-1476. 10.1002/art.34315, 22143922.
32. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, Salter D, van den Berg WB. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 2006, 14:13-29. 10.1016/j.joca.2005.07.014, 16242352.
33. De Nardo CM, Lenzo JC, Pobjoy J, Hamilton JA, Cook AD. Urokinase-type plasminogen activator and arthritis progression: contrasting roles in systemic and monoarticular arthritis models. Arthritis Res Ther 2010, 12:R199. 10.1186/ar3171, 2991036, 20973954.
34. Mercuri FA, Maciewicz RA, Tart J, Last K, Fosang AJ. Mutations in the interglobular domain of aggrecan alter matrix metalloproteinase and aggrecanase cleavage patterns. Evidence that matrix metalloproteinase cleavage interferes with aggrecanase activity. J Biol Chem 2000, 275:33038-33045.
35. van Meurs JB, van Lent PL, Holthuysen AE, Bayne EK, van den Berg WB. Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis. Arthritis Rheum 1999, 42:1128-1139. 10.1002/1529-0131(199906)42:6<1128::AID-ANR9>3.0.CO;2-2, 10366105.
36. Hughes CE, Caterson B, Fosang AJ, Roughley PJ, Mort JS. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro. Biochem J 1995, 305(Pt 3):799-804. 1136329, 7531436.
37. Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol 2010, 6:625-635. 10.1038/nrrheum.2010.159, 20924410.
38. Hamilton JA, Tak PP. The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases. Arthritis Rheum 2009, 60:1210-1221. 10.1002/art.24505, 19404968.
39. Felson DT, Gale DR, Elon Gale M, Niu J, Hunter DJ, Goggins J, Lavalley MP. Osteophytes and progression of knee osteoarthritis. Rheumatology (Oxford) 2005, 44:100-104.
40. Kortekaas MC, Kwok WY, Reijnierse M, Huizinga TW, Kloppenburg M. Osteophytes and joint space narrowing are independently associated with pain in finger joints in hand osteoarthritis. Ann Rheum Dis 2011, 70:1835-1837. 10.1136/ard.2010.147553, 21742640.
41. Joosten LA, Helsen MM, van den Berg WB. Protective effect of rimexolone on cartilage damage in arthritic mice: a comparative study with triamcinolone hexacetonide. Agents Actions 1990, 31:135-142. 10.1007/BF02003233, 2285019.
42. van Lent PL, Blom AB, van der Kraan P, Holthuysen AE, Vitters E, van Rooijen N, Smeets RL, Nabbe KC, van den Berg WB. Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formation. Arthritis Rheum 2004, 50:103-111. 10.1002/art.11422, 14730606.
43. Schweizerhof M, Stosser S, Kurejova M, Njoo C, Gangadharan V, Agarwal N, Schmelz M, Bali KK, Michalski CW, Brugger S, Dickenson A, Simone DA, Kuner R. Hematopoietic colony-stimulating factors mediate tumor-nerve interactions and bone cancer pain. Nat Med 2009, 15:802-807. 10.1038/nm.1976, 19525966.
44. Blom AB, van der Kraan PM, van den Berg WB. Cytokine targeting in osteoarthritis. Curr Drug Targets 2007, 8:283-292. 10.2174/138945007779940179, 17305506.
45. Hamilton JA. A colony-stimulating factor network involving mononuclear phagocytes and other cells. Haemopoietic Growth Factors and Mononuclear Phagocytes 1993, 29-35. Basel: Karger, van Furth R.
46. van Meurs JB, van Lent PL, Bayne EK, van de Loo FA, van den Berg WB. Interleukin-1 receptor antagonist prevents expression of the metalloproteinase-generated neoepitope VDIPEN in antigen-induced arthritis. Arthritis Rheum 1998, 41:647-656. 10.1002/1529-0131(199804)41:4<647::AID-ART11>3.0.CO;2-T, 9550473.